YFFI yields 4.71% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, YFFI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YFFI + PFE for your $10,000?
YFFI invests in investment grade fixed income securities of any maturity. The fund targets corporate bonds but may hold US Treasurys, asset-backed securities, and preferred stocks perceived to offer attractive cash flow and yield. It assesses relative yield or the typical yield spread differences between bonds and the yield difference for the same company issuing both corporate debt and preferred stocks. In addition, the fund analyzes fundamental and technical data for credit rating, coupon, yield to worst, and maturity date. Weights are then assigned using these variables relative to their target company and sector exposure. The fund selects securities that maximize cash flow and yield based on current and expected market conditions and the portfolios current composition. Holdings are reviewed monthly, while the models are reviewed quarterly for possible reconstitution. However, as an actively managed ETF, the fund manager has full discretion to buy or sell securities at any time.
Full YFFI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.